16
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T81495 | PhD2 | ||
PhD2, an antimicrobial peptide originating from monkey leukocytes, exhibits efficacy against bacteria and the fungus Candida albicans [1]. | |||
T79241 | PHD2-IN-1 | HIF/HIF Prolyl-Hydroxylase | |
PHD2-IN-1, a potent and orally active HIF prolyl hydroxylase 2 (PHD2) inhibitor, exhibits an IC50 of 22.53 nM and is applicable in anemia research [1]. | |||
T62298 | PHD2/HDACs-IN-1 | ||
PHD2/HDACs-IN-1 is a potent mixed inhibitor of PHD2/HDACs, acting on PHD2 (IC50: 1.15 μM), HDAC1 (IC50: 19.75 μM), HDAC2 (IC50: 26.60 μM), HDAC16 (IC50: 15.98 μM). HDACs-IN-1 is a low toxicity nephroprotective agent that... | |||
T22022 | Adaptaquin | HIF | |
Adaptaquin is an inhibitor of the hypoxia-inducing factor prolyl hydroxylase (HIF-PH) [1] [2]. | |||
T2445 | FG-2216 | YM-311,FG2216,FG 2216 | HIF/HIF Prolyl-Hydroxylase |
FG-2216 (YM-311) is a potent HIF-prolyl hydroxylase inhibitor for the PDH2 enzyme (IC50: 3.9 uM); orally bioavailable and induced reversible and significant Epo induction in vivo. | |||
T7880 | IOX4 | HIF/HIF Prolyl-Hydroxylase | |
IOX4 is a potent PHD2 inhibitor (IC50 = 1.6 nM) | |||
T5392 | TP0463518 | HIF/HIF Prolyl-Hydroxylase | |
TP-0463518 is a highly potent HIF prolyl hydroxylase (PHD) inhibitor (IC50s: 13 nM and 18 nM for human and rat PHD2, respectively). | |||
T4106 | MK-8617 | MK8617 | HIF/HIF Prolyl-Hydroxylase |
MK-8617 is an orally available HIF PHD1 3 pan-inhibitor, inhibiting PHD1/2/3 (IC50: 1.0/1.0/14 nM). | |||
T1823 | IOX2 | IOX 2,JICL38 | HIF/HIF Prolyl-Hydroxylase |
IOX2 (IOX 2) is a selective inhibitor of the Hypoxia Inducible Factor (HIF) Prolyl-Hydroxylases (PHD); active in cells with the IC50 value of 21 nM for PHD2/ELGN-1 and no inhibition at FIH (20uM). | |||
T3180 | JNJ-42041935 | HIF-PHD Inhibitor II | HIF/HIF Prolyl-Hydroxylase |
JNJ-42041935 (HIF-PHD Inhibitor II) is a potent (pKi = 7.3-7.9), 2-oxoglutarate competitive, reversible, and selective inhibitor of PHD enzymes. | |||
T26880 | BNS | ||
BNS is a potent, prolyl-hydroxylase 2 (PHD2)-selective inhibitor. | |||
T39040 | HIF-PHD-IN-1 | ||
HIF-PHD-IN-1 is a pharmacological compound that acts as an orally active inhibitor of the hypoxia-inducible factor prolyl hydroxylase domain (HIF-PHD), displaying an IC50 of 54 nM for hHIF-PHD2. Its potential as a therap... | |||
T79797 | PHD-IN-1 | HIF/HIF Prolyl-Hydroxylase | |
PHD-IN-1 (compound 80) serves as a potent PHD2 inhibitor, exhibiting an IC50 value of ≤5 nM. It demonstrates EC50 values of 2.5 μM in EPO Elisa assays within both Caco2-HIF1a-HiBiT-clone-1 and Hep3B cell lines [1]. | |||
T61458 | HIF-PHD-IN-2 | ||
HIF-PHD-IN-2 (compound 25) is a highly effective PHD inhibitor, displaying IC50 values below 100 nM for PHD1, PHD2, and PHD3 [1]. | |||
T68511 | KRH102140 | ||
KRH102140 is a potent activator of PHD2. KRH102140, which has a structure similar to KRH102053. KRH102140 more efficiently suppressed HIF-1α than KRH102053 in human osteosarcoma cells under hypoxia. Furthermore, KRH10214... | |||
T37198 | Ethyl LipotF | ||
Selective FTO inhibitor (IC50 = 0.81 μM). Exhibits >30-fold selectivity for FTO over ALKBH2, 3 and 5 and >100-fold selectivity over PHD2 and JMJD2A. Increases levels of modified N6-methyladenosine (m6A) in HeLa cells in ... |